fda on compounded tirzepatide Tirzepatide, FDA, and Compounding: Understanding the Current Landscape 2026 FDA Rules and News

PMID 34304009

Aesthetically, the loss of muscle can reveal or worsen skin laxity, leading to concerns about hollowing in the face and changes in body contour, often described by patients as Ozempic face

Thyroid Medication and GLP-1 Therapy If youre on thyroid medications such as levothyroxine, liothyronine, or desiccated thyroid extract, weight loss from GLP-1 therapy could increase your risk of hyperthyroidism

Oz nor Oprah endorsed any specific gelatin product

Note about allergens: Although all our products are formulated to avoid common allergens, allergies can occur to any new product used on your skin

References Kahrilas PJ, Kim HC, Pandolfino JE